Skip to main content

CITADEL ADVISORS LLC

Position in GRAL — GRAIL, Inc.

CIK 1423053 MIAMI, FL

Position in GRAL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,751,641
-$4,019,435 QoQ
Shares Held
33,894
-49.7% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in GRAL Over Time

Shares Held

Position Value (USD)

Derivatives in GRAL

reported options exposure · as of Mar 31, 2026
CallValue
$10,423,856
CallShares
201,700
PutValue
$3,173,152
PutShares
61,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $1,657,068,556 across 34 Diagnostics & Research names. GRAL ranks #25 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GRAL

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,751,641 33,894
2026-03-31 $3,173,152 61,400
2026-03-31 $10,423,856 201,700
2025-12-31 $12,920,666 150,960
2025-12-31 $6,401,447 74,792
2025-12-31 $5,771,076 67,427
2025-09-30 $3,346,521 56,596
2025-09-30 $8,402,373 142,100
2025-06-30 $6,858,605 133,384
2025-06-30 $10,235,253 199,052
2025-03-31 $1,380,896 54,068
2025-03-31 $4,447,433 174,136
2025-03-31 $3,905,857 152,931
2024-12-31 $5,048,711 282,841
2024-12-31 $1,564,873 87,668
2024-12-31 $1,850,259 103,656
2024-09-30 $949,935 69,036
2024-09-30 $983,330 71,463
2024-09-30 $947,788 68,880
2024-06-30 $440,873 28,684
2024-06-30 $401,034 26,092
2024-06-30 $4,670,143 303,848